메뉴 건너뛰기
The Lancet Infectious Diseases
Volumn 14, Issue 9, 2014, Pages 783-784
Dengue virus and host antibody: A dangerous balancing act
Author keywords

[No Author keywords available]
Indexed keywords

ANTIBODY;
EID: 84906936698     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(14)70843-6     Document Type: Note
Times cited : (2)
References (12)
  • 1
    • 84876804736 scopus 로고    scopus 로고
    • The global distribution and burden of dengue
    • Bhatt S, Gething PW, Brady OJ, et al. The global distribution and burden of dengue. Nature 2013, 496:504-507.
    • (2013) Nature , vol.496 , pp. 504-507
    • Bhatt, S.1    Gething, P.W.2    Brady, O.J.3
  • 2
    • 84868211668 scopus 로고    scopus 로고
    • Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
    • Sabchareon A, Wallace D, Sirivichayakul C, et al. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. Lancet 2012, 380:1559-1567.
    • (2012) Lancet , vol.380 , pp. 1559-1567
    • Sabchareon, A.1    Wallace, D.2    Sirivichayakul, C.3
  • 3
    • 84906936457 scopus 로고    scopus 로고
    • Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study
    • published online July 24.
    • Osorio JE, Velez ID, Thomson C, et al. Safety and immunogenicity of a recombinant live attenuated tetravalent dengue vaccine (DENVax) in flavivirus-naive healthy adults in Colombia: a randomised, placebo-controlled, phase 1 study. Lancet Infect Dis 2014, published online July 24. http://dx.doi.org/10.1016/S1473-3099(14)70843-6.
    • (2014) Lancet Infect Dis
    • Osorio, J.E.1    Velez, I.D.2    Thomson, C.3
  • 4
    • 0014136680 scopus 로고
    • The enhancement of virus infectivity by antibody
    • Hawkes RA, Lafferty KJ The enhancement of virus infectivity by antibody. Virology 1967, 33:250-261.
    • (1967) Virology , vol.33 , pp. 250-261
    • Hawkes, R.A.1    Lafferty, K.J.2
  • 5
    • 0019314426 scopus 로고
    • An explanation for enhanced virus plaque formation in chick embryo cells
    • Kliks S, Halstead SB An explanation for enhanced virus plaque formation in chick embryo cells. Nature 1980, 285:504-505.
    • (1980) Nature , vol.285 , pp. 504-505
    • Kliks, S.1    Halstead, S.B.2
  • 6
    • 0015784492 scopus 로고
    • Studies on the pathogenesis of dengue infection in monkeys. II. clinical laboratory responses to heterologous infection
    • Halstead SB, Shotwell H, Casals J Studies on the pathogenesis of dengue infection in monkeys. II. clinical laboratory responses to heterologous infection. J Infect Dis 1973, 128:15-22.
    • (1973) J Infect Dis , vol.128 , pp. 15-22
    • Halstead, S.B.1    Shotwell, H.2    Casals, J.3
  • 7
    • 77957160633 scopus 로고    scopus 로고
    • Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes
    • Halstead S, Mahalingam S, Marovich MA, Ubol S, Mosser DM Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes. Lancet Infect Dis 2010, 10:712-722.
    • (2010) Lancet Infect Dis , vol.10 , pp. 712-722
    • Halstead, S.1    Mahalingam, S.2    Marovich, M.A.3    Ubol, S.4    Mosser, D.M.5
  • 8
    • 0024565393 scopus 로고
    • Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever
    • Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS Antibody-dependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg 1989, 40:444-451.
    • (1989) Am J Trop Med Hyg , vol.40 , pp. 444-451
    • Kliks, S.C.1    Nisalak, A.2    Brandt, W.E.3    Wahl, L.4    Burke, D.S.5
  • 9
    • 22544457161 scopus 로고    scopus 로고
    • Dengue virus (DV) enhancing antibody activity in preillness plasma does not predict subsequent disease severity or viremia in secondary DV infection
    • Laoprasopwattana K, Libraty DH, Endy TP, et al. Dengue virus (DV) enhancing antibody activity in preillness plasma does not predict subsequent disease severity or viremia in secondary DV infection. J Infect Dis 2005, 192:510-519.
    • (2005) J Infect Dis , vol.192 , pp. 510-519
    • Laoprasopwattana, K.1    Libraty, D.H.2    Endy, T.P.3
  • 10
    • 0033970916 scopus 로고    scopus 로고
    • Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity
    • Vaughn DW, Green S, Kalayanarooj S, et al. Dengue viremia titer, antibody response pattern, and virus serotype correlate with disease severity. J Infect Dis 2000, 181:2-9.
    • (2000) J Infect Dis , vol.181 , pp. 2-9
    • Vaughn, D.W.1    Green, S.2    Kalayanarooj, S.3
  • 11
    • 0036569001 scopus 로고    scopus 로고
    • Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections
    • Libraty DH, Endy TP, Houng HS, et al. Differing influences of virus burden and immune activation on disease severity in secondary dengue-3 virus infections. J Infect Dis 2002, 185:1213-1221.
    • (2002) J Infect Dis , vol.185 , pp. 1213-1221
    • Libraty, D.H.1    Endy, T.P.2    Houng, H.S.3
  • 12
    • 84883597357 scopus 로고    scopus 로고
    • Identifying protective dengue vaccines: guide to mastering an empirical process
    • Halstead SB Identifying protective dengue vaccines: guide to mastering an empirical process. Vaccine 2013, 31:4501-4507.
    • (2013) Vaccine , vol.31 , pp. 4501-4507
    • Halstead, S.B.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.